Head-to-head · Cost-Efficiency Index
InstaRX vs Spry
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
InstaRX
Cost-first shoppers who want one flat price at every dose, for shoppers who don't want to guess what a dose increase will cost.
Visit InstaRXSpry
Shoppers who want compounded GLP-1 bundled with anti-aging peptides from one named founding team.
Visit SpryThe verdict
InstaRX and Spry tie on the Cost-Efficiency Index at 67/100, so neither wins outright on the numbers. For most shoppers we'd start with InstaRX (ranked #139, a hair above #140) — Cost-first shoppers who want one flat price at every dose, for shoppers who don't want to guess what a dose increase will cost. But Spry is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs InstaRX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | InstaRX | Spry |
|---|---|---|
| Cost-Efficiency Index | 67/100 | 67/100 |
| Semaglutide / mo | $179/mo | $199/mo (all doses, compounded) |
| Tirzepatide / mo | $259/mo | $299/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,148 | $2,388 |
| Tirzepatide / yr (modeled) | $3,108 | $3,588 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #139 | #140 |
InstaRX
67/100Where the value is
- Flat 'same price any dose' model for both drugs ($179/mo semaglutide, $259/mo tirzepatide) — no dose-tier guesswork
- Free expedited shipping stated explicitly
- States medications come 'exclusively from U.S. pharmacies'
The tradeoffs
- The homepage's own '$199 to get started' figure is never explained anywhere on the site — unclear if it's a one-time signup charge, the first month's payment, or an additional charge on top of the $179/$259 monthly prices
- No medical director or named prescriber anywhere — only generic 'third-party professional healthcare providers' language
Spry
67/100Where the value is
- Real, named founding team with individual bios — confirmed live on the About page
- Pricing shown directly on the homepage and product pages, no sign-up wall required
- Explicitly describes its GLP-1s as compounded rather than leaving formulation ambiguous
The tradeoffs
- No dose-tier price breakdown is published for either drug
- No compounding pharmacy is named anywhere on the pages checked
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.